ACTIVE

PHARMACIE CASTRIQUE

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result39,1 k €+3 411,6 %over 1 year
Gross margin196,7 k €+32,4 %over 1 year
Equity419,8 k €+10,3 %over 1 year
Workforce2,5 ETP+13,6 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE CASTRIQUE is a Public limited company incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Comines-Warneton. It employs on average 2,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0433.926.728
Incorporation
31/03/1988
Legal form
Public limited company
Registered office
Rue de Ten-Brielen(COM) 77
7780 Comines-Warneton · WallonieSee on map
Contributed capital
62 000,00 €
Latest accounts
30/06/2025
Average workforce
2,5 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 17 financial years

20252024202320222019
Income statement
Gross margin196,7 k €148,5 k €168 k €240,9 k €80,9 k €
EBITDA51,3 k €12 k €38,5 k €162,8 k €15,7 k €
Operating result49,5 k €253,4 €9,2 k €125,8 k €-30,1 k €
Net result39,1 k €1,1 k €6,7 k €106,3 k €-48,6 k €
Balance sheet
Equity419,8 k €380,7 k €379,6 k €372,9 k €231,6 k €
Total assets928,9 k €944,5 k €843,1 k €1,2 M €890,8 k €
Cash62,2 k €153,6 k €34,2 k €84,6 k €76,9 k €
Debts506,5 k €562,1 k €461,9 k €778,1 k €655,8 k €
Other
Workforce2,5 ETP2,2 ETP2,1 ETP1,1 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 20 ended

Active mandates

Edward Vansteelant

Director · since 05 juin 2024 · until 07 décembre 2030

Active
Jocelyne Leterme

Chairman of the board of directors · since 05 juin 2024 · until 07 décembre 2030

Active
PHARMGETH

Director · since 05 juin 2024 · until 07 décembre 2030 · 0471.524.819

Represented by Vansteelant Filip

Active

Ended mandates

PHARMGETH

Director · since 05 juin 2024 · until 07 décembre 2030 · 0471.524.819

Represented by Vansteelant FILIP

Ended
Filip Vansteelant

Director · since 02 mai 2016

Ended
Jocelyne Leterme

Chairman of the board of directors · since 02 mai 2016

Ended
PHARMGETH

Director · since 02 mai 2016 · 0471.524.819

Represented by Vansteelant FILIP

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/09/202614/02/202531/01/202426/01/202301/02/202226/02/2021
General meeting03/09/202607/12/202402/12/202303/12/202204/12/202106/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202503/09/202615/09/2026FrenchPDF
Abridged model30/06/202407/12/202414/02/2025FrenchPDF
Abridged model30/06/202302/12/202331/01/2024FrenchPDF
Abridged model30/06/202203/12/202226/01/2023FrenchPDF
Abridged model30/06/202104/12/202101/02/2022FrenchPDF
Abridged model30/06/202006/02/202126/02/2021FrenchPDF
Abridged model30/06/201907/12/201926/02/2020FrenchPDF
Abridged model30/06/201801/12/201826/02/2019FrenchPDF
Abridged model30/06/201702/12/201707/02/2018FrenchPDF
Abridged model31/12/201502/05/201631/08/2016FrenchPDF
Abridged model31/12/201402/05/201528/10/2015FrenchPDF
Abridged model31/12/201302/05/201429/09/2014FrenchPDF
Abridged model31/12/201202/05/201329/11/2013FrenchPDF
Abridged model31/12/201102/05/201226/11/2012FrenchPDF
Abridged model31/12/201002/05/201128/11/2011FrenchPDF
Abridged model31/12/200903/05/201020/12/2010FrenchPDF
Abridged model31/12/200802/05/200930/11/2009FrenchPDF
Abridged model31/12/200702/05/200831/12/2008FrenchPDF
Abridged model31/12/200602/05/200724/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 20 ended

Active mandates

Edward Vansteelant

Director · since 05 juin 2024 · until 07 décembre 2030

Active
Jocelyne Leterme

Chairman of the board of directors · since 05 juin 2024 · until 07 décembre 2030

Active
PHARMGETH

Director · since 05 juin 2024 · until 07 décembre 2030 · 0471.524.819

Represented by Vansteelant Filip

Active

Ended mandates

PHARMGETH

Director · since 05 juin 2024 · until 07 décembre 2030 · 0471.524.819

Represented by Vansteelant FILIP

Ended
Filip Vansteelant

Director · since 02 mai 2016

Ended
Jocelyne Leterme

Chairman of the board of directors · since 02 mai 2016

Ended
PHARMGETH

Director · since 02 mai 2016 · 0471.524.819

Represented by Vansteelant FILIP

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/07/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Other17/01/2017
    ASSEMBLEE GENERALE - ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates05/12/2016
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/04/2013
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/08/2005
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/06/2004
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/02/2004
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202539,1 k €↑
  2. 2024
    Annual accounts 20241,1 k €↓
  3. 2023
    Annual accounts 20236,7 k €↓
  4. 2022
    Annual accounts 2022106,3 k €↑
  5. 2019
    Annual accounts 2019-48,6 k €↓
  6. 2018
    Annual accounts 2018-45,8 k €↓
  7. 2017
    Annual accounts 201771,9 k €↑
  8. 2015
    Annual accounts 2015-16,2 k €↑
  9. 2014
    Annual accounts 2014-21,6 k €↓
  10. 2013
    Annual accounts 2013-6,2 k €↓
  11. 2012
    Annual accounts 2012808,5 €↓
  12. 2011
    Annual accounts 201118,4 k €↓
  13. 2010
    Annual accounts 201056,9 k €↑
  14. 2009
    Annual accounts 200937,5 k €↑
  15. 2008
    Annual accounts 200814,9 k €↓
  16. 2007
    Annual accounts 200725 k €↑
  17. 2006
    Annual accounts 200619,1 k €
  18. 31/03/1988
    IncorporationPublic limited company